Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|July 31, 2012
Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signalingCheng-Yu Tsai, J Cameron Finley, Sameh S Ali, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2003
Cross-resistance to cisplatin in cells with acquired resistance to copperRoohangiz Safaei, Kuniyuki Katano, Goli Samimi, et al.
Molecular Pharmacology|July 2, 2004
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cellsAlison K Holzer, Goli Samimi, Kuniyuki Katano, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 20, 2006
Expression of the human copper influx transporter 1 in normal and malignant human tissuesAlison K Holzer, Nissi M Varki, Quynh T Le, et al.
Molecular Pharmacology|March 3, 2010
Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cellsBrian G Blair, Christopher A Larson, Preston L Adams, et al.
Molecular Pharmacology|October 23, 2002
Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanineMaida M de las Alas, Gerrit Los, Xinjian Lin, et al.
Human Pathology|March 26, 2005
Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancersSharon P Wilczynski, Yuan-Yuan Chen, Wengang Chen, et al.
Molecular Cancer Therapeutics|July 2, 2009
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptorsXiaoqin Yuan, Xinjian Lin, Gerald Manorek, et al.
Biochemical Pharmacology|May 11, 2010
The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatinChristopher A Larson, Preston L Adams, Danielle D Jandial, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cellsGoli Samimi, Roohangiz Safaei, Kuniyuki Katano, et al.
Pageof 11